Agenus Inc - Aug 24, 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/ Christine Klaskin, Vice President, Finance
Stock symbol
INKT
Transactions as of
Aug 24, 2023
Transactions value $
$281,478
Form type
4
Date filed
8/28/2023, 05:15 PM
Previous filing
May 12, 2023
Next filing
Aug 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $263K +170K +0.79% $1.54 21.7M Aug 24, 2023 Direct F1, F2
transaction INKT Common Stock Purchase $18.6K +12.8K +0.06% $1.45 21.7M Aug 28, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.5443 (range of $1.52 to $1.55).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a weighted average price of $1.4499 (range of $1.44 to $1.45).